Press Releases

Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, today announces that it has completed phase I clinical trials of Lorediplon in insomnia. The trials demonstrated the orally available compound has a best-in-class...

Cambridge, UK, February 8 2012 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today formally announces that it has established its global headquarters in Cambridge, UK. The opening of the new global HQ follows a year of...

Rainbow Biosciences, the biotech division of Rainbow Coral Corp. announced today that it’s on the cusp of a major breakthrough in its business relationship with n3D Biosciences. Last week, management from RBCC and n3D convened to...

Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com) is investigating possible consumer claims against Pfizer, Inc. relating to its recent recall of certain lots of Lo/Ovral®-28 and Norgestrel birth control pills that were sold in the U.S. ...

Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity Musculoskeletal Conference on February 7th at 3:30pm PT at the Parc 55 Wyndham in...

Alize Pharma II, a drug development company focused on oncology and metabolism and part of the Alize Pharma group, announced today the signing of a licensing agreement with EUSA Pharma for ASPAREC(R), a new L-asparaginase product currently in...

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that Peter Barrett, a partner at Atlas Venture, an early stage technologies and life sciences venture capital fund, has...